11 July 2025 in Journal of Neurology
SHSophie-Maria Hierholzer
F(For The German Stroke Registry -Endovascular Treatment (Gsr-Et)
For The German Stroke Registry -Endovascular Treatment (Gsr-Et)
+11
Background and purpose: First pass (FP) recanalization, defined as achieving mTICI 2b or higher in a single thrombectomy attempt, has been linked to better functional recovery in acute ischemic stroke patients. This study aimed to investigate whether the benefits of FP are primarily driven by higher rates of complete reperfusion (mTICI 3) or by faster procedure times. Methods: Data from 3707 patients with middle cerebral artery occlusion and successful recanalization (mTICI 2b or higher) were extracted from the prospectively designed German Stroke Registry (2015–2021). Good functional outcomes were defined as a modified Rankin Scale (mRS) score of ≤ 2 at 90 days. Mediation analysis was used to evaluate the extent to which complete reperfusion (mTICI 3) and shorter groin puncture to recanalization time contributed to improved outcomes. Results: FP recanalization was associated with significantly better functional outcomes: 46.9% of FP patients achieved an mRS ≤ 2 compared to 37.2% in the multi-pass group. Mediation analysis showed that only 14% of the improved outcomes with FP were explained by higher mTICI 3 rates, while 37% were attributed to faster recanalization times. Conclusion: The improved outcomes associated with FP recanalization are primarily driven by the speed of reperfusion rather than the degree of complete recanalization. This highlights the importance of minimizing procedure times and the number of thrombectomy attempts. Strategies aimed at optimizing treatment workflows and improving device design to prioritize early and efficient reperfusion after the FP are critical to improving patient outcomes (ClinicalTrials.gov identifier: NCT03356392).
12 November 2025 in Clinical Pharmacology & Therapeutics
Knowledge of the glomerular filtration rate (GFR) is mandatory when dosing renally eliminated drugs such as vancomycin. In clinical practice, different biomarkers and various equations are used to estimate GFR (eGFR), resulting in varying estimates. These variations may be explained by nonrenal factors, such as muscle status or glucocorticoid administration. This study aimed to evaluate the performance of different eGFR equations in terms of accuracy and precision compared to renal vancomycin clearance, including subgroup analyses for nonrenal confounders. We retrospectively analyzed data from 121 adult allogeneic hematopoietic stem cell transplant (allo‐HSCT) patients. All patients received vancomycin treatment including trough concentration therapeutic drug monitoring. The eGFR was calculated using eight equations and compared to the renal vancomycin clearance that was calculated using a pharmacokinetic model and served as the reference. Individual muscle status was determined by computed tomography scans. Median renal vancomycin clearance was 49 mL/minute/1.73 m 2 (range 24–96). All eight eGFR equations overestimated renal vancomycin clearance. The six (partially) creatinine‐based equations were significantly less accurate (bias: 24.0–62.8 mL/minute/1.73 m 2 ) than both cystatin C‐based equations (bias: 6.3–9.5 mL/minute/1.73 m 2 ). This decreased accuracy for creatinine‐based eGFR was more pronounced in patients with reduced muscle status or glucocorticoid medication. All CKD‐EPI equations and the Hoek equation were more precise with an IQR of the difference to renal vancomycin clearance ≤22.5 mL/minute/1.73 m 2 compared to ≥35.5 mL/minute/1.73 m 2 (Cockcroft‐Gault, MDRD). In conclusion, cystatin C‐based eGFR equations are preferable to creatinine‐based approaches for vancomycin dosing in allo‐HSCT patients.
9 October 2026 in Journal of Neurology
Background: Intracranial stenting (ICS) is used as a rescue strategy in patients with failed reperfusion after endovascular thrombectomy (EVT). However, real-world data on clinical outcomes and safety remain limited. Methods: This retrospective analysis of prospectively collected data from the German Stroke Registry—Endovascular Treatment (GSR-ET) included patients with acute ischemic stroke due to middle cerebral artery (MCA) occlusion treated between June 2015 and December 2023. Patients undergoing ICS were compared with a 1:1 propensity score–matched cohort with failed reperfusion after EVT (final modified Thrombolysis in Cerebral Infarction [mTICI] score <2b) who received no further endovascular treatment. Functional, safety, and subgroup outcomes were assessed. Results: Among the 14,714 eligible patients, ICS was performed in 352 (2.4%). After matching, 218 patients undergoing ICS were compared with 218 controls with failed reperfusion. ICS was associated with a shift toward better 90-day functional outcomes in unadjusted (cOR 0.52, 95% CI 0.37–0.73; p <0.01) and adjusted analyses (acOR 0.41, 95% CI 0.29–0.59; p <0.01). Malignant MCA infarction occurred less frequently in the ICS group (1% vs. 8%; p <0.01), as did 90-day mortality (26% vs. 37%; p =0.02). Symptomatic intracranial hemorrhage did not differ between groups (4% vs. 5%; p =0.63). Conclusions: Patients treated with ICS had a shift toward better functional outcomes and lower 90-day mortality than those with failed reperfusion who received no further endovascular treatment. Symptomatic intracranial hemorrhage did not differ between groups. These findings support further investigation of ICS after failed EVT, although randomized studies are needed to determine its efficacy and safety.
13 March 2026 in Clinical Neuroradiology
G(German Stroke Registry – Endovascular Treatment (Gsr-Et)
German Stroke Registry – Endovascular Treatment (Gsr-Et)
+11
Purpose: The treatment effect of mechanical thrombectomy in patients with mild stroke symptoms and large vessel occlusion remains unclear. Furthermore, it is uncertain whether achieving complete reperfusion (modified Thrombolysis in Cerebral Infarction [mTICI] 3) offers additional clinical benefit compared to incomplete reperfusion (mTICI 2b) in patients with mild stroke. Methods: In this retrospective, multicenter analysis, all patients enrolled in the German Stroke Registry—Endovascular Treatment between 2015 and 2023 ( n = 18,069) were evaluated. The study included patients with a National Institutes of Health Stroke Scale (NIHSS) score of < 6 and anterior circulation large vessel occlusion. Clinical outcomes were compared between mTICI 2b and mTICI 3. The primary endpoint was excellent functional outcome at 90 days, defined as a modified Rankin Scale (mRS) score of 0–1. Results: Of the 747 included patients, 37% achieved mTICI 2b and 63% mTICI 3. An excellent functional outcome was observed at similar rates in both groups (mTICI 2b: 59% vs. mTICI 3: 60%; P = 0.83; adjusted OR: 0.96 [95% CI: 0.66–1.40]; P = 0.84). The rates of symptomatic intracranial hemorrhage (4% vs. 3%; P = 0.36) and 90-day mortality (10% vs. 7%; P = 0.26; adjusted OR: 0.80 [95% CI: 0.42–1.50]; P = 0.49) were also comparable between the two groups. Conclusion: Among thrombectomy patients with mild stroke, complete reperfusion was not associated with better functional outcomes than incomplete reperfusion. These findings suggest that mTICI 2b may be an acceptable final angiographic result and raise questions about the risk-benefit ratio of additional retrieval maneuvers aimed at achieving mTICI 3.